Does SummaCare Cover Viagra?

How SummaCare Handles Erectile Dysfunction Medications

SummaCare, a regional managed-care organization headquartered in Akron, Ohio, structures its prescription drug coverage through a tiered formulary that separates medications by cost and clinical preference. Brand-name Viagra (sildenafil citrate, Pfizer) lost its U.S. patent exclusivity in December 2017, and since then, most commercial and Medicare Advantage formularies have shifted coverage toward the generic version [1].

On SummaCare's published formularies for both its commercial HMO/PPO products and its Medicare Advantage plans, brand Viagra is typically listed as non-formulary or excluded entirely. This means filling a brand-name prescription would require the member to pay the full retail price. Generic sildenafil, by contrast, appears on most SummaCare drug lists at Tier 2 (preferred generic) or Tier 3 (non-preferred generic), depending on plan year and product line. The FDA approved generic sildenafil in December 2017 from multiple manufacturers, confirming bioequivalence to brand Viagra through standard abbreviated new drug application (ANDA) pathways [2].

Members who specifically want brand Viagra can submit a formulary exception request. SummaCare's exception process requires a prescriber to document medical necessity, such as a documented adverse reaction to the generic formulation. Approval rates for these exceptions are low. The reason is straightforward: the FDA requires generic sildenafil to contain the same active ingredient, dose, route, and bioequivalence profile as the brand [3].

What Generic Sildenafil Coverage Looks Like on SummaCare Plans

For members with a SummaCare commercial or marketplace plan, generic sildenafil is generally covered with a copay ranging from $5 to $30 per fill, depending on the specific benefit design and chosen pharmacy. Preferred pharmacies within SummaCare's network yield the lowest cost-sharing. That copay structure can bring the per-tablet cost to under $2 for a 30-day supply of six tablets.

Quantity limits are standard across nearly all insurance plans that cover phosphodiesterase type 5 (PDE5) inhibitors. SummaCare typically caps sildenafil at 6 tablets per 30 days for erectile dysfunction. Some plans allow up to 12. This aligns with the prescribing information, which recommends sildenafil 50 mg taken approximately one hour before sexual activity, with a maximum frequency of once daily [4]. The American Urological Association (AUA) guidelines on erectile dysfunction identify PDE5 inhibitors as first-line pharmacotherapy for most men, noting that all four available agents (sildenafil, tadalafil, vardenafil, avanafil) show similar efficacy rates of 60% to 70% [5].

Prior authorization requirements vary by plan tier. SummaCare Medicare Advantage plans are more likely to require PA for ED medications than commercial plans, reflecting Centers for Medicare & Medicaid Services (CMS) guidance that allows but does not mandate Part D coverage of ED drugs [6]. If PA is required, the prescriber must confirm a diagnosis of erectile dysfunction (ICD-10 code N52.x) and document that the patient is not taking concurrent nitrate therapy, which is an absolute contraindication [7].

SummaCare Medicare Advantage and Part D: A Separate Formulary

Medicare Part D coverage of erectile dysfunction medications has a complicated history. From 2006 through 2012, CMS explicitly excluded ED drugs from Part D coverage. The Affordable Care Act did not mandate their inclusion. Starting in 2013, Part D sponsors gained the option to cover these agents, but many chose not to [8].

SummaCare's Medicare Advantage plans operating in Ohio counties (Summit, Stark, Portage, Medina, Wayne, and surrounding areas) have varied in their ED drug coverage by plan year. Members should verify their specific plan's formulary each enrollment period because coverage can change annually. The SummaCare member portal and the Medicare Plan Finder tool at medicare.gov both display current formulary details.

For SummaCare Medicare Advantage members whose plan does not cover sildenafil, there is an important workaround. Sildenafil 20 mg tablets (originally marketed as Revatio for pulmonary arterial hypertension) are often covered under a different formulary category. A prescriber can write sildenafil 20 mg with instructions to take two or three tablets (40 to 60 mg) before sexual activity. This off-label dosing for ED uses the same molecule at a comparable dose. The per-tablet cost for sildenafil 20 mg is often lower than sildenafil 50 mg or 100 mg tablets, sometimes under $0.50 per tablet at preferred pharmacies [9].

Cost Comparison: Brand Viagra vs. Generic Sildenafil vs. Alternatives

The price gap between brand Viagra and its generic equivalent is large. Brand Viagra carries a wholesale acquisition cost (WAC) of approximately $82 per 100 mg tablet. Generic sildenafil 100 mg tablets, which can be split to create two 50 mg doses, are available from wholesale distributors at $0.30 to $1.50 per tablet depending on manufacturer and purchase volume [10].

For SummaCare members weighing their options, here is a practical cost breakdown. A brand Viagra prescription for six 100 mg tablets costs roughly $490 retail without coverage. The same quantity in generic sildenafil 100 mg runs $2 to $15 retail before insurance. With SummaCare Tier 2 coverage, the copay for generic sildenafil is typically $5 to $15. The math favors the generic by a factor of 30 or more.

Tadalafil (generic Cialis) presents another covered alternative on most SummaCare formularies. Tadalafil offers a longer duration of action (up to 36 hours compared to sildenafil's 4 to 6 hours) and is available in a 5 mg daily dosing option for men who prefer continuous readiness rather than on-demand use [11]. The ENDURANCE trial compared tadalafil 5 mg daily against sildenafil 50 mg on demand in 184 men and found no significant difference in overall sexual satisfaction, though tadalafil scored higher on the spontaneity domain of the International Index of Erectile Function (IIEF) questionnaire [12].

SummaCare may apply step therapy to tadalafil, requiring a trial of sildenafil first. Step therapy protocols are designed to start with the lowest-cost effective agent. If sildenafil fails or causes intolerable side effects (headache occurs in 16% of users, flushing in 10%, dyspepsia in 7% according to the prescribing label), the prescriber can document the failure and request tadalafil approval [4].

How to Check Your Specific SummaCare Formulary

Not all SummaCare plans use the same drug list. The organization offers commercial HMO, commercial PPO, Medicare Advantage HMO, and Medicare Advantage PPO products across its Ohio service area. Each product line publishes its own formulary annually, with mid-year updates possible.

Three reliable methods exist for checking coverage. First, log into the SummaCare member portal at summacare.com and search the formulary lookup tool using "sildenafil" as the drug name. Second, call SummaCare's pharmacy services line printed on the back of the member ID card. Third, ask your pharmacist to run a real-time benefit check (RTBC), which queries your plan's adjudication system and returns exact copay, quantity limit, and PA requirements at the point of sale. Real-time benefit tools became mandatory for Medicare Part D plans under the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), published in January 2024 [13].

If the formulary search returns "not covered" for sildenafil, the member or prescriber can file a coverage determination request. SummaCare is required to respond within 72 hours for standard requests and 24 hours for expedited requests under Ohio Department of Insurance regulations and CMS Part D timelines [14].

Prior Authorization: What Your Doctor Needs to Submit

When SummaCare requires prior authorization for sildenafil, the process follows a standard template. The prescriber submits clinical documentation confirming the ED diagnosis, the patient's age (sildenafil is FDA-approved for adult males 18 and older), concurrent medications (specifically confirming no nitrate use), and any relevant cardiovascular history [7].

The AUA's 2018 guideline update emphasizes that PDE5 inhibitors carry a Class I recommendation for first-line ED treatment in men without contraindications [5]. Cardiovascular risk stratification is recommended before prescribing. The Princeton III Consensus Panel classifies men into low, intermediate, and high cardiovascular risk categories, with low-risk patients cleared for PDE5 inhibitor use without additional cardiac workup [15]. SummaCare's PA criteria generally align with these consensus recommendations.

Approval turnaround is typically 24 to 48 hours for commercial plans and up to 72 hours for Medicare Advantage. Denials can be appealed through SummaCare's internal grievance process, and if the internal appeal fails, Ohio members have access to an independent external review through the Ohio Department of Insurance.

When SummaCare Denies Coverage: Alternative Pathways

A denial does not mean paying $80 per pill. Several cost-reduction strategies work outside insurance entirely.

Manufacturer discount cards are not available for generic sildenafil (there is no single brand manufacturer), but pharmacy discount programs such as GoodRx, RxSaver, and Cost Plus Drugs can bring generic sildenafil 100 mg (split for two doses) to $2 to $8 for a 30-day supply. Mark Cuban's Cost Plus Drugs pharmacy lists sildenafil 20 mg at $0.17 per tablet as of early 2026, which translates to approximately $0.50 per ED dose when using three 20 mg tablets [16].

Telehealth platforms, including HealthRX, offer prescribed sildenafil with transparent pricing that bypasses insurance formulary restrictions. For men frustrated by PA requirements or quantity limits, direct-pay telehealth consultations can provide a prescription within 24 hours.

Avanafil (Stendra) represents a newer PDE5 inhibitor option with a faster onset (15 minutes vs. sildenafil's 30 to 60 minutes) and potentially fewer visual side effects. It remains brand-only and is not covered by most SummaCare formularies, but its manufacturer offers a savings card reducing the copay to $0 for commercially insured patients meeting eligibility criteria [17].

"Clinicians should inform patients that all PDE5 inhibitors have comparable efficacy, and the choice between agents should be guided by patient preference regarding onset, duration, and side-effect profile," states the AUA's 2018 erectile dysfunction guideline panel [5].

Sildenafil Safety Considerations That Affect Coverage Decisions

Insurance coverage policies for PDE5 inhibitors are shaped partly by safety data. The FDA's post-marketing surveillance database (FAERS) has recorded rare but serious adverse events including non-arteritic anterior ischemic optic neuropathy (NAION) and sudden sensorineural hearing loss [18]. The absolute risk is extremely small. A retrospective cohort study published in JAMA Ophthalmology (N = 278,601 men with new PDE5 inhibitor prescriptions) found no statistically significant increase in NAION risk (adjusted hazard ratio 1.02 to 95% CI 0.92 to 1.12) [19].

The contraindication with nitrates remains the primary safety concern driving PA requirements. Concurrent use of sildenafil and any nitrate (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) can cause severe hypotension. "The interaction between PDE5 inhibitors and nitrates is absolute and non-negotiable. There is no safe interval shorter than 24 hours for sildenafil or 48 hours for tadalafil," notes the Princeton III Consensus guidelines [15]. SummaCare's PA form specifically requires prescribers to attest that the patient is not using nitrates.

Alpha-blocker co-administration requires caution but is not an absolute contraindication. The AUA guidelines recommend starting sildenafil at 25 mg in patients stabilized on alpha-blocker therapy for benign prostatic hyperplasia (BPH), with dose adjustment based on response [5].

Ohio-Specific Insurance Regulations Affecting ED Drug Coverage

Ohio law does not mandate insurance coverage of erectile dysfunction medications. This distinguishes it from states like Illinois and New York, which have broader prescription coverage mandates. SummaCare, as an Ohio-domiciled insurer regulated by the Ohio Department of Insurance (ODI), sets its formulary within the boundaries of federal requirements (for Medicare Advantage) and state minimum essential health benefit benchmarks (for marketplace plans).

The Ohio Essential Health Benefits (EHB) benchmark plan, derived from the largest small-group plan in the state, does not specifically include ED medications in its required drug categories [20]. This means SummaCare and other Ohio insurers have discretion over whether to include PDE5 inhibitors. Most choose to cover generic options because the cost is minimal and member demand is high.

For SummaCare members enrolled through the Health Insurance Marketplace (ACA plans), the prescription drug benefit must cover at least one drug per United States Pharmacopeia (USP) therapeutic category. PDE5 inhibitors fall under USP category "Genitourinary Agents," and SummaCare satisfies this requirement by covering generic sildenafil or tadalafil on at least one plan tier.